Traveling can be a challenging experience for anyone, but for those living with Multiple Sclerosis (MS), it often comes with ...

Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.

MRT-6160 is under clinical development by Monte Rosa Therapeutics and currently in Phase I for Multiple Sclerosis.

A multiple sclerosis patient shares essential guidance from her 13-year diagnostic journey, offering hope and practical tips ...

ACT-10041239 is under clinical development by Idorsia Pharmaceutical and currently in Phase I for Multiple Sclerosis.

Analysis of Biogen's stock performance in 2024, focusing on sales struggles, financial health, and valuation. Read more here.

Teri Garr, best known for her roles in Tootsie and Mr. Mom, has passed away at the age of 79. After a career spanning decades ...

Certain health issues seen in youth with MS in the five years before diagnosis confirm a prodromal period may exist in ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

Children and adolescents with multiple sclerosis (MS) have a range of symptoms, signs, and diagnoses within five years before ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...